𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II pilot of concommitant radiation therapy and weekly Cis-platinum, vincristine, and bleomycin in advanced head and neck cancer

✍ Scribed by P.G. Shankar Giri; Sarah A. Taylor; Eashwer K. Reddy

Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
234 KB
Volume
10
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concomitant radiation therapy and cis-di
Concomitant radiation therapy and cis-diamminedichloroplatinum (II) in patients with advanced head and neck cancer
✍ Creagan, Edward T. ;Fountain, Karen S. ;Frytak, Stephen ;Desanto, Lawrence W. ;E 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

## Abstract Three patients with locally advanced head and neck squamous cell cancer received concomitant radiation therapy (XRT) and cis‐diamminedichloroplatinum (CDDP). The dose of 6,000 rads was to be administered in two 3,000‐rad courses separated by 3 weeks. The CDDP, 30 mg/m^2^, was to be give

Combination chemotherapy with cis-diammi
Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer phase II
✍ Magid H. Amer; Ronald M. Izbicki; V. K. Vaitkevicius; Muhyi Al-Sarraf 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 771 KB

Comb in a tio n Ch em o therapy with Cis-Dia m m in e dic h lo ropla tin um , On c o vin , an d Bleo m ycin (COB) in Advanced Head and Neck Cancer Phase I1 MAGID H. AMER, MD, FRCS (ENG.), FRCP(C),\* RONALD M. IZBICKI, DO,\* V. K. VAITKEVICIUS, MD, FACP,t AND MUHYI AL-SARRAF, MD, FRCP(C), FACP\* Twen

cis-Platinum and 5-fluorouracil as initi
cis-Platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck
✍ Weaver, Arthur ;Fleming, Susan ;Vandenberg, Henry ;Drelichman, Anibal ;Jacobs, J 📂 Article 📅 1982 🏛 Wiley (John Wiley & Sons) ⚖ 397 KB

## Abstract A total of 44 patients with previously untreated Stage IV squamous cell carcinomas of the head and neck were treated with a combination of cis‐platinum (100 mg/sq m) and 96‐hour infusion of 5‐fluorouracil (5‐FU) (1,000 mg/sq m/day) in two courses or with cis‐platinum (100 mg/sq m) and 1